Trial Methodology

CNS Summit 2020 Abstracts of Poster Presentations

ICNS Online Editor | June 21, 2021

A message from the editor Dear Colleagues: Welcome to the annual CNS Summit Abstracts of Poster Presentations supplement to Innovations in Clinical Neuroscience. We are pleased to provide you with this reference guide to some of the innovative research that was presented during the CNS Summit 2020 event. The supplement is also available online by […]

Do Patterns of Instability or Severity of Psychopathology During Screening Predict Relapse in Schizophrenic Outpatient Subjects with Moderate to Severe Negative Symptoms Assigned to Placebo?

ICNS Online Editor | January 1, 2020

The Effect of Acutely Administered Propofol on Forced Swim Test Outcomes in Mice

ICNS Online Editor | September 1, 2019

Correlation Between the Movement Disorder Society’s Unified Parkinson’s Disease Rating Scale and Nonmotor Scales in Patients with Parkinson’s Disease

ICNS Online Editor | September 1, 2019

CNS Summit 2019 Abstracts of Poster Presentations

ICNS Online Editor | September 1, 2019

A message from the editor: Dear Colleagues: Welcome to the annual CNS Summit Abstracts of Poster Presentations supplement to Innovations in Clinical Neuroscience. We are pleased to provide you with this reference guide to some of the innovative research that is being presented during CNS Summit 2019. The supplement is also available online by visiting […]

Is High Placebo Response Really a Problem in Depression Trials? A Critical Re-analysis of Depression Studies

ICNS Online Editor | July 1, 2019

Letter to the Editor: The Click-through Rate as a Measure of Dementia Health Promotion on YouTube

ICNS Online Editor | July 1, 2019

Olanzapine Plus Samidorphan in Subjects with Schizophrenia and Comorbid Alcohol Use Disorder: Rationale and Design for a Phase II, Double-blind, Randomized Study

ICNS Online Editor | May 1, 2019

Adult Neurogenesis in Humans: A Review of Basic Concepts, History, Current Research, and Clinical Implications

ICNS Online Editor | May 1, 2019

Therapeutic Potential of Ponesimod Alone and in Combination with Dimethyl Fumarate in Experimental Models of Multiple Sclerosis

ICNS Online Editor | March 1, 2019

Trial Methodology

CNS Summit 2020 Abstracts of Poster Presentations

Do Patterns of Instability or Severity of Psychopathology During Screening Predict Relapse in Schizophrenic Outpatient Subjects with Moderate to Severe Negative Symptoms Assigned to Placebo?

The Effect of Acutely Administered Propofol on Forced Swim Test Outcomes in Mice

Correlation Between the Movement Disorder Society’s Unified Parkinson’s Disease Rating Scale and Nonmotor Scales in Patients with Parkinson’s Disease

CNS Summit 2019 Abstracts of Poster Presentations

Is High Placebo Response Really a Problem in Depression Trials? A Critical Re-analysis of Depression Studies

Letter to the Editor: The Click-through Rate as a Measure of Dementia Health Promotion on YouTube

Olanzapine Plus Samidorphan in Subjects with Schizophrenia and Comorbid Alcohol Use Disorder: Rationale and Design for a Phase II, Double-blind, Randomized Study

Adult Neurogenesis in Humans: A Review of Basic Concepts, History, Current Research, and Clinical Implications

Therapeutic Potential of Ponesimod Alone and in Combination with Dimethyl Fumarate in Experimental Models of Multiple Sclerosis

Login

Follow us

Latest E-Edition

Complete Journal Archives

Website Archives

Download the ICNS app